In a new study on the UK Biobank cohort, habitual coffee or caffeine consumption, especially at a moderate level, was associated with a lower risk of new-onset cardiometabolic multimorbidity, which refers to the coexistence of at least two cardiometabolic diseases.

A new study from the UK Biobank cohort reveals that moderate coffee or caffeine consumption is linked to a reduced risk of developing cardiometabolic multimorbidity, which involves the coexistence of at least two cardiometabolic diseases. Researchers found that individuals consuming about three cups of coffee daily (200-300 mg of caffeine) had a 48.1% lower risk of new-onset cardiometabolic issues compared to non-consumers. The study included over 172,000 participants without pre-existing cardiometabolic diseases and tracked their health outcomes through various data sources. Overall, moderate caffeine intake appeared to be inversely associated with nearly all developmental stages of cardiometabolic conditions. The findings highlight the potential benefits of moderate coffee consumption in reducing the risk of these diseases.

This just doesn’t seem like news. There are nearly a dozen studies looking at the Biobank database showing that reported coffee consumption in this cohort is associated with better outcomes on cardiac and other indicators. So…someone ran the stats in a slightly novel way and it showed the same outcome?

Examples: [https://academic.oup.com/eurjpc/article/29/17/2240/6704995](https://academic.oup.com/eurjpc/article/29/17/2240/6704995)

[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282813/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282813/)

[https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2686145](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2686145)

[https://www.nature.com/articles/s41598-018-25919-2#Sec2](https://www.nature.com/articles/s41598-018-25919-2#Sec2) (Biobank is the biggest cohort in this one, but it does include others)

etc